HRT Financial’s HPX Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant HPX.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-212,234
Closed -$2.12M 3778
2022
Q2
$2.12M Hold
212,234
0.02% 544
2022
Q1
$2.13M Hold
212,234
0.02% 617
2021
Q4
$2.14M Hold
212,234
0.01% 623
2021
Q3
$2.13M Hold
212,234
0.01% 690
2021
Q2
$2.19M Hold
212,234
0.02% 580
2021
Q1
$2.16M Sell
212,234
-400
-0.2% -$4.4K 0.02% 576
2020
Q4
$2.24M Buy
212,634
+400
+0.2% +$4.08K 0.05% 301
2020
Q3
$2.16M Buy
+212,234
New +$2.15M 0.06% 222

Other funds holding HPX.U

HRT Financial's HPX.U Position: Q3 2022 in Review

HRT Financial sold out of HPX Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant (HPX.U) in Q3 2022, closing a stake of 212,234 shares — an estimated $2.12M sold.

HRT Financial first reported a position in HPX.U in Q3 2020 and held it in 8 quarters. The position peaked at $2.24M in Q4 2020. 4 funds tracked by Wall St. Rank hold HPX.U as of Q3 2022.

  • HRT Financial reported no remaining HPX Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant position as of Q3 2022 after selling out during the quarter.
  • HRT Financial sold 212,234 HPX Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant shares in Q3 2022, an estimated $2.12M.
  • HRT Financial first reported a position in HPX Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant in Q3 2020 and held it in 8 quarters.
  • HRT Financial's HPX Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant position peaked at $2.24M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held HPX Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.